NCT07009340

Brief Summary

This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 6, 2025

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

1.6 years

First QC Date

May 29, 2025

Last Update Submit

June 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-discharge outcomes for patients enrolled in REN-004 from one study center

    Readmission for any reason Rehospitalization related to procedure/valve/heart failure Contacts with HCP post discharge (any HCP) PCP (if available) All tests and procedures post discharge Medications Chronic kidney disease (CKD) - new diagnosis Acute kidney injury (AKI) requiring dialysis Chronic Kidney disease (CKD) requiring dialysis Atrial fibrillation - new-onset Myocardial infarction (MI) Non-fatal cardiac arrest Reoperation for coronary artery bypass graft (CABG) Reoperation for valve dysfunction Stroke Death from any cause MACCE Death from any cause, repeat revascularization (CABG or PCI), non-fatal MI, and stroke

    1 year

Secondary Outcomes (1)

  • Total estimated cost of in hospital and post-discharge

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who completed REN-004 and have at least 1 year of follow documentation post-discharge

You may qualify if:

  • Patient completed REN-004
  • Patient has at least 1 year of follow documentation post-discharge

You may not qualify if:

  • Patient enrolled in a clinical trial within 1-year post-discharge from REN-004

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Heart Center Research, LLC

Huntsville, Alabama, 35801, United States

Location

Lutheran Medical Center

Fort Wayne, Indiana, 46804, United States

Location

My Michigan Medical Center

Midland, Michigan, 48670, United States

Location

University of Texas Southwestern Medical Center

Dallas, Texas, 75399, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 6, 2025

Study Start

November 18, 2023

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations